High- versus low-dose proton pump inhibitors after endoscopic hemostasis in patients with peptic ulcer bleeding: A multicentre, randomized study

American Journal of Gastroenterology

Volumn 103, Issue 12, 2008, Pages 3011-3018

  Andriulli, Angelo ^a   Loperfido, Silvano ^b   Focareta, Rosaria ^c   Leo, Pietro ^d   Fornari, Fabio ^e   Garripoli, Antonietta ^f   Tonti, Paolo ^g   Peyre, Sergio ^h   Spadaccini, Antonio ⁱ   Marmo, Riccardo ^j   Merla, Antonio ^a   Caroli, Alessandro ^b   Forte, Gian Battista ^c   Belmonte, Angelo ^d   Aragona, Giovanni ^e   Imperiali, Gianni ^k   Forte, Fabrizio ^c   Monica, Fabio ^b   Caruso, Nazario ^a   Perri, Francesco ^a  

^a CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

^b Regional Hospital   (Italy)

^c S Sebastiano Hospital   (Italy)

^d Annunziata Hospital   (Italy)

^e GUGLIELMO DA SALICETO HOSPITAL   (Italy)

^f MARIA VITTORIA HOSPITAL   (Italy)

^g OSPEDALI RIUNITI   (Italy)

^h Ospedale di Ivrea   (Italy)

ⁱ S Pio da Pietrelcina Hospital   (Italy)

^j L Curto Hospital   (Italy)

^k VALDUCE HOSPITAL   (Italy)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; OMEPRAZOLE; PANTOPRAZOLE; PROTON PUMP INHIBITOR; SODIUM CHLORIDE;

AGED; ARTICLE; BLOOD TRANSFUSION; BOLUS INJECTION; CLINICAL TRIAL; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG MEGADOSE; ENDOSCOPY; FATALITY; FEMALE; HEMATEMESIS; HEMOSTASIS; HIGH RISK POPULATION; HOSPITALIZATION; HUMAN; LENGTH OF STAY; LOADING DRUG DOSE; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MELENA; MULTICENTER STUDY; OUTCOME ASSESSMENT; PATIENT SELECTION; PEPTIC ULCER BLEEDING; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; RISK REDUCTION; COMPARATIVE STUDY; MIDDLE AGED; RECURRENT DISEASE;

AGED; DOUBLE-BLIND METHOD; FEMALE; HEMOSTASIS, ENDOSCOPIC; HUMANS; MALE; MIDDLE AGED; PEPTIC ULCER HEMORRHAGE; PROTON PUMP INHIBITORS; RECURRENCE;

EID: 58149384462     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2008.02149.x     Document Type: Article

References (31)

1. British Society of Gastroenterology Endoscopy Committee. Non-variceal upper gastrointestinal hemorrhage: Guidelines. Gut 2002 51 (Suppl 4 iv1 6.
2. Barkun A, Bardou M, Marshall JK, for the Nonvariceal Upper GI Bleeding Consensus Conference Group. Consensus recommendations for managing patients with nonvariceal upper gastrointestinal bleeding. Am Intern Med 2003 139 : 843 57.
3. Green FW Jr., Kaplan MM, Curtis LE, et al. Effect of acid and pepsin on blood coagulation and platelet aggregation. A possible contributor prolonged gastroduodenal mucosal hemorrhage. Gastroenterology 1978 74 : 38 43.
4. Patchett SE, Enright H, Afdhal N, et al. Clot lysis by gastric juice: An in vitro study. Gut 1989 30 : 1074 7.
5. Schaffalitzky de Muckadell UB, Havelund T, Harling H, et al. Effects of omeprazole on the outcome of endoscopically treated peptic ulcers. Scand J Gastroenterol 1997 32 : 320 7.
6. Lau JYW, Sung JJY, Lee KKC, et al. Effect of intravenous omeprazole on recurrent bleeding after endoscopic treatment of bleeding peptic ulcers. N Engl J Med 2000 343 : 310 6.
7. Schonekas H, Ahrens H, Pannewick U, et al. Comparison of two doses of intravenous pantoprazole in peptic ulcer bleeding. Gastroenterology 1999 116 : A305.
8. Udd M, Miettinen P, Palmu A, et al. Regular-dose versus high-dose omeprazole in peptic ulcer bleeding: A prospective randomized double-blind study. Scand J Gastroenterol 2001 36 : 1332 8.
9. Dokas SM, Lazaraki GI, Kontoninas Z, et al. Bolus intravenous omeprazole b.i.d vs. continuous intravenous omeprazole infusion combined with endoscopic hemostasis in the treatment of peptic ulcer bleeding. Preliminary results. Gut 2004 53 (Suppl VI A290.
10. Bajaj JS, Dua KS, Hanson K, et al. Prospective, randomized trial comparing effect of oral versus intravenous pantoprazole on rebleeding after nonvariceal upper gastrointestinal bleeding: A pilot study. Dig Dis Sci 2007 52 : 2190 4.
11. Andriulli A, Annese V, Caruso N, et al. Proton-pump inhibitors and outcome of endoscopic hemostasis in bleeding peptic ulcer: A series of meta-analysis. Am J Gastroenterol 2005 100 : 207 19.
12. Rockall TA, Logan RF, Devlin HB, et al. Risk assessment after acute upper gastrointestinal haemorrhage. Gut 1996 38 : 316 21.
13. Leontiadis GI, Sharma VK, Howden CW. Proton pump inhibitor treatment for acute peptic ulcer bleeding. Cochrane Database Syst Rev 2006 1 : CD0020947.
14. Saeed ZA, Ramirez FC, Hepps KS, et al. Prospective validation of the Baylor bleeding score for predicting the likelihood of rebleeding after endoscopic hemostasis of peptic ulcers. Gastrointest Endosc 1995 41 : 561 5.
15. Lin HJ, Lo WC, Chen YC, Perng CL. Role of intravenous omeprazole in patients with high-risk of peptic ulcer bleeding after successful endoscopic epinephrine injection: A prospective randomized comparative trial. Am J Gastroenterol 2006 101 : 500 5.
16. Hasselgren G, Lind T, Lundell L, et al. Continuous intravenous infusion of omeprazole in elderly patients with peptic ulcer bleeding: Results of a placebo controlled multicenter study. Scand J Gastroenterol 1997 32 : 328 33.
17. Khuroo MS, Farahat KL, Kagevi IE. Treatment with proton pump inhibitors in acute non-variceal upper gastrointestinal bleeding: A meta-analysis. J Gastroenterol Hepatol 2005 20 : 11 25.
18. Cardi M, Muttillo IA, Amadori L, et al. Oméprazole versus ranitidine intraveineux dans le traitment de l'ulcère duodénal hémorragique: Une étude randomisée prospective. Ann Chir 1997 51 : 136 9.
19. Labenz J, Peitz U, Leusing C, et al. Efficacy of primed infusions with high dose ranitidine and omeprazole to maintain high intragastric pH in patients with peptic ulcer bleeding: A prospective randomised controlled study. Gut 1997 40 : 36 41.
20. Fried R, Beglinger C, Meier R, et al. Comparison of intravenous pantoprazole with intravenous ranitidine in peptic ulcer bleeding. Gut 1999 45 (Suppl V A100.
21. Lin HJ, Lo WC, Lee FY, et al. A prospective randomised comparative trial showing tat omeprazole prevents rebleeding in patients with bleeding peptic ulcer after endoscopic therapy. Arch Intern Med 1998 158 : 54 8.
22. Spiegel BM, Dulai GS, Lim BS, et al. The cost-effectiveness and budget impact of intravenous versus oral proton pump inhibitors in peptic ulcer hemorrhage. Clin Gastroenterol Hepatol 2006 4 : 988 97.
23. Barkun AN, Herba K, Adam V, et al. The cost-effectiveness of high-dose oral proton pump inhibition after endoscopy in the acute treatment of peptic ulcer bleeding. Aliment Pharmacol Ther 2004 20 : 195 202.
24. Netzer P, Gaia C, Sandoz M, et al. Effect of repeated injection and continuous infusion of omeprazole and ranitidine on intragastric pH over 72 h. Am J Gastroenterol 1999 94 : 351 7.
25. Metz DC, Amer F, Hunt B, et al. Lansoprazole regimens that sustain intragastric pH >6: AN evaluation of intermittent oral and continuous intravenous lansoprazole or ranitidine. Aliment Pharmacol Ther 1999 23 : 985 95.
26. Welage LS, Berardi RR. Evaluation of omeprazole, lansoprazole, pantoprazole, and rabeprazole in the treatment of acid-related diseases. J Am Pharm Assoc 2000 40 : 52 62.
27. Chilovi F, Piazzi L, Zancanella L, et al. Intravenous omeprazole and pantoprazole after endoscopic treatment of bleeding peptic ulcers. Gastrointest Endosc 2003 57 : AB150.
28. Marmo R, Rotondano G, Piscopo R, et al. Dual therapy versus monotherapy in the endoscopic treatment of high-risk bleeding ulcers: A meta-analysis of controlled trial. Am J Gastroenterol 2007 102 : 279 89.
29. ASGE guideline: The role of endoscopy in acute non-variceal upper-GI hemorrhage. Gastrointest Endosc 2004 60 : 497 504.
30. Pilotto A, Franceschi M, Longoa MG, et al. Helicobacter pylori infection and the prevention of peptic ulcer with proton pump inhibitors in elderly subjects taking low-dose aspirin. Dig Liver Dis 2004 36 : 666 70.
31. Jensen DM, Pace SC, Soffer E, et al., and members of the 315 Study Group. Continuous infusion of pantoprazole versus ranitidine for prevention of ulcer rebleeding: A U.S. multicenter randomized, double-blind study. Am J Gastroenterol 2006 101 : 1991 9.